Discover how early CMC, process optimization, and formulation strategy drive scalable, commercially viable drugs.
Jan 05, 2026 // Heading into 2026, the geopolitical and global governance short–term outlooks look perilous. Yet many ...
Sherry Gu, Executive Vice President and CTO at WuXi Biologics, explains the critical challenges of developing bispecific ...
NASA’s Mars Sample Return program faces opposition from planetary scientists following proposed cancellation, with concerns raised over Perseverance samples, future Mars missions, and international ...
ATRIMED today shared an update on a long running research effort led in part by physician scientist Dr. Latha Damle, whose ...
ChibaTech's instrument package includes a multiband imaging camera onboard the ExLabs mothership and deployable Cubesat-shaped landers (called CubeLanders), designed to study the asteroid's surface ...
True ROI for R&D won't come from the tool that generates 10,000 new ideas. It will come from the tool that confidently tells ...
Newquay-based Green Park Pharma, which specialises in developing liquid formulations of existing medications, has completed a multimillion-pound funding round.
AI prioritizes clinical trials by identifying unmet medical needs, optimizing resource allocation, and focusing on conditions ...
But some of it comes to the United States. It is not an accident that the E.L.N., the guerrilla group that’s heavily engaged ...
Commonwealth Charter Academy's growth presents a challenge to Pa.'s traditional public schools. But lawsuits and budget cuts ...
Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH), a public company trading on the OTC Markets under the ticker ...